Vivos Inc (RDGL)

[Nadendla]

Simply speaking..Battelle is a leading international science and technology enterprise in the WORLD!!...that explores emerging areas of science and develops and commercializes technology...Here they see something that is different from how we as traders look at..Thats why they grabbed their 11% of TOTAL Common stock of ADMD!!..These guys are Super Big. ..BTW..Don't forget where we are at..and where this fell from..NO dilly dallying here..either you are IN or OUT!!..:)



http://www.battelle.org/

Battelle is the world's largest independent research and development organization. Headquartered

in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide. Battelle has managed the U.S.

Department of Energy's Pacific Northwest National Laboratory in Richland, Wash., since the laboratory's inception in 1965

.

KENNEWICK, Wash., July 7, 2014 (PRNewswire) – Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a late

stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for

diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of

AMIC’s outstanding Common Stock. Battelle is a leading international science and technology enterprise that explores

emerging areas of science and develops and commercializes technology.

In 2011, AMIC entered into license agreements with Battelle for 10 patents related to AMICs brachytherapy products; and

in 2012, AMIC entered into an exclusive license agreement with Battelle for use of Battelle’s patented brachytherapy gel

technology.

AMIC CEO and Chairman James C. Katzaroff stated: “AMIC and Battelle’s joint commercialization effort was nationally

recognized in 2013, when AMIC received the Federal Laboratory Consortium Award for Excellence in

Technology Transfer, a prestigious honor recognized by the US Secretary of Energy and U.S. Senator Patty Murray. We

continue our close collaboration with Battelle and look forward to commercializing this exciting technology.

”

Battelle acquired its interest in AMIC by converting a note previously issued for partial consideration of studies

conducted at PNNL. Details are reported in the Company’s Form 8K filed with the Securities and Exchange Commission.

As previously announced, AMIC is in the process of securing FDA approval for its Y-90 RadioGel™ brachytherapy device. As

AMIC recently announced, the FDA has determined that the RadioGel™ brachytherapy product is a Class III medical device,

unless reclassified as a Class II device. That determination is being reviewed, along with the steps AMIC should take for

approval. AMIC is engaged in discussions with the FDA through the Pre-Submission process, including an in person meeting.

About Battelle

Every day, the people of Battelle apply science and technology to solving what matters most. At major

technology centers and national laboratories around the world, Battelle conducts research and development, designs and

manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus,

Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and

environmental industries. Battelle operates Pacific Northwest National Laboratory in Richland, Wash., for the U.S.

Department of Energy. For more information, visit www.battelle.org.

http://www.isotopeworld.com/products/brachytherapy/

ADMD